Choice of imaging modality in the assessment of coronary artery disease risk in extreme obesity

Obesity

Volumn 18, Issue 1, 2010, Pages 1-6

  Dunn, Julia P ^a   Huizinga, Mary M ^b   See, Raphael ^a   Irani, Waleed N ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; HUMAN; METHODOLOGY; MORBID OBESITY; REVIEW; RISK;

CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; HUMANS; OBESITY, MORBID; RISK;

EID: 73949124391     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.150     Document Type: Review

References (49)

1. Bibbins-Domingo K, Coxson P, Pletcher MJ Lightwood J, Goldman L. Adolescent overweight and future adult coronary heart disease. N Engl J Med 2007;357:2371-2379.
2. Hensrud DD, Klein S. Extreme obesity: a new medical crisis in the United States. Mayo Clin Proc 2006;81(10Suppl):S5-S10.
3. Must A, Spadano J, Coakley EH et al. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-1529
4. Mokdad AH, Ford ES, Bowman BA et al Prevalence of obesity diabetes, and obesity-related health risk factors, 2001 JAMA 2003;289:76-79
5. Karason K, Lindroos AK, Stenlöf K, Sjöström L. Relief of cardiorespiratory symptoms and increased physical activity after surgically induced weight loss: results from the Swedish Obese Subjects study. Arch Intern Med 2000;160:1797-1802.
6. Alpert MA, Terry BE, Cohen MV et al. The electrocardiogram in morbid obesity. Am J Cardiol 2000;85:908-910, A10.
7. Resta O, Foschino-Barbaro MP, Legari G et al. Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord 2001;25:669-675
8. Mokhlesi B, Kryger MH, Grunstein RR. Assessment and management of patients with obesity hypoventilation syndrome. Proc Am Thorac Soc 2008;5:218-225. (Pubitemid 351237881)
9. Duvall WL, Croft LB, Corriel JS et al. SPECT myocardial perfusion imaging in morbidly obese patients: image quality, hemodynamic response to pharmacologic stress, and diagnostic and prognostic value. J Nucl Cardiol 2006;13:202-209.
10. Pfeffer MA, Braunwald E, Moyé LA et al Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial The SAVE Investigators. N Engl J Med 1992;327:669-677
11. Persic V, Ruzic A, Miletic B et al. Left ventricle diastolic dysfunction in obese patients with newly diagnosed arterial hypertension. Wien Klin Wochenschr 2007;119:423-427
12. Otto ME, Belohlavek M, Romero-Corral A et al Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 2007;99:1298-1302
13. Rocha IE, Victor EG, Braga MC, Barbosa e Silva O, Becker Mde M. Echocardiography evaluation for asymptomatic patients with severe obesity. Arq Bras Cardiol 2007;88:52-58.
14. Catheline JM, Bihan H, Le Quang T et al Preoperative cardiac and pulmonary assessment in bariatric surgery. Obes Surg 2008;18:271-277
15. Schlant R, Alexander RW, O'Rourke RA, Roberts R, Sonnenblick EH (eds). Hurst's The Heart, 8th edn. McGraw-Hill: New York, 1994.
16. Moir S, Marwick TH. Combination of contrast with stress echocardiography: a practical guide to methods and interpretation. Cardiovasc Ultrasound 2004;2:15.
17. Kitzman DW, Goldman ME, Gillam LD et al Efficacy and safety of the novel ultrasound contrast agent perflutren (Definity) in patients with suboptimal baseline left ventricular echocardiographic images. Am J Cardiol 2000;86:669-674
18. Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. Circulation 1991;83 363-381
19. Klocke FJ, Baird MG, Lorell BH et al. ACC/ AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/ASNC Committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). J Am Coll Cardiol 2003;42:1318-1333.
20. Berman DS, Kang X, Nishina H et al. Diagnostic accuracy of gated Tc-99m sestamibi stress myocardial perfusion SPECT with combined supine and prone acquisitions to detect coronary artery disease in obese and nonobese patients. J Nucl Cardiol 2006;13:191-201
21. DePuey EG III. How to detect and avoid myocardial perfusion SPECT artifacts. J Nucl Med 1994;35:699-702.
22. Hansen CL, Woodhouse S, Kramer M. Effect of patient obesity on the accuracy of thallium-201 myocardial perfusion imaging. Am J Cardiol 2000;85:749-752
23. Thompson RC, Heller GV, Johnson LL et al Value of attenuation correction on ECG-gated SPECT myocardial perfusion imaging related to body mass index. J Nucl Cardiol 2005;12:195-202
24. Bybel B, Brunken RC, DiFilippo FP et al SPECT/CT imaging: clinical utility of an emerging technology. Radiographics 2008;28:1097-1113.
25. Akincioglu C, Belhocine T, Gambhir S et al Abstract: added value of SPECT-CT in obese patients undergoing myocardial perfusion imaging. J Nucl Med 2007;48(Suppl 2):230P.
26. Corbett J, Kritzman J, Cahill J, Ficaro E. Abstract: hybrid cardiac SPECT/CT for attenuation correction of stress myocardial perfusion imaging in obese patients. J Nucl Med 2008;49(Suppl 1):73P.
27. Elhendy A, Schinkel AF, van Domburg RT et al. Prognostic stratification of obese patients by stress 99mTc-tetrofosmin myocardial perfusion imaging. J Nucl Med 2006;47:1302-1306.
28. Singh B, Bateman TM, Case JA, Heller G. Attenuation artifact, attenuation correction and the future of myocardial perfusion SPECT. J Nucl Cardiol 2007;14:153-164.
29. Di Carli MF, Hachamovitch R. New technology for noninvasive evaluation of coronary artery disease. Circulation 2007;115:1464-1480
30. Yoshinaga K, Chow BJ, Williams K et al What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol 2006;48:1029-1039
31. Sampson UK, Dorbala S, Limaye A, Kwong R, Di Carli MF. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/ computed tomography in the detection of coronary artery disease. J Am Coll Cardiol 2007;49:1052-1058.
32. Hundley WG, Kizilbash AM, Afridi I et al. Effect of contrast enhancement on transthoracic echocardiographic assessment of left ventricular regional wall motion. Am J Cardiol 1999;84:1365-1368,A8.
33. Nagel E, Lehmkuhl HB, Bocksch Wet al Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999;99:763-770.
34. Poldermans D, Fioretti PM, Boersma E et al Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: a single-center experience. Circulation 1999;99:757-762.
35. Hu SJ, Liu SX, Katus HA, Luedde M The value of contrast dobutamine stress echocardiography on detecting coronary artery disease in overweight and obese patients. Can J Cardiol 2007;23:885-889.
36. Lerakis S, Kalogeropoulos AP, El-Chami MF et al. Transthoracic dobutamine stress echocardiography in patients undergoing bariatric surgery. Obes Surg 2007;17:1475-1481
37. Lambertz H, Kreis A, Trümper H, Hanrath P. Simultaneous transesophageal atrial pacing and transesophageal two-dimensional echocardiography: a new method of stress echocardiography. J Am Coll Cardiol 1990;16:1143-1153.
38. Zabalgoitia M, Gandhi DK, Abi-Mansour P et al Transesophageal stress echocardiography: detection of coronary artery disease in patients with normal resting left ventricular contractility Am Heart J 1991;122:1456-1463
39. Agati L, Renzi M, Sciomer S et al Transesophageal dipyridamole echocardiography for diagnosis of coronary artery disease. J Am Coll Cardiol 1992;19:765-770.
40. Panza JA, Laurienzo JM, Curiel RV Quyyumi AA, Cannon RO. Transesophageal dobutamine stress echocardiography for evaluation of patients with coronary artery disease. J Am Coll Cardiol 1994;24:1260-1267.
41. Madu EC. Transesophageal dobutamine stress echocardiography in the evaluation of myocardial ischemia in morbidly obese subjects. Chest 2000;117:657-661
42. Bhat G, Daley K, Dugan M, Larson G. Preoperative evaluation for bariatric surgery using transesophageal dobutamine stress echocardiography. Obes Surg 2004;14 948-951
43. Garimella S, Longaker RA, Stoddard MF. Safety of transesophageal echocardiography in patients who are obese. J Am Soc Echocardiogr 2002;15:1396-1400.
44. Vitarelli A, Dagianti A, Conde Y et al. Value of transesophageal dobutamine stress echocardiography in assessing coronary artery disease. Am J Cardiol 2000;86 57G-60G.
45. McNulty PH, Ettinger SM, Field JM et al Cardiac catheterization in morbidly obese patients. Catheter Cardiovasc Interv 2002;56:174-177.
46. Wigfield CH, Lindsey JD, Muñoz A et al Is extreme obesity a risk factor for cardiac surgery? An analysis of patients with a BMI > or = 40. Eur J Cardiothorac Surg 2006;29 434-440.
47. Prabhakar G, Haan CK, Peterson ED et al The risks of moderate and extreme obesity for coronary artery bypass grafting outcomes: a study from the Society of Thoracic Surgeons' database. Ann Thorac Surg 2002;74:1125-1130; discussion 1130-1131
48. Smith SC Jr, Blair SN, Bonow RO et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update.
49. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 2001;38:1581-1583